March 2008
Worldwide Biotech;Mar2008, Vol. 20 Issue 3, p1
Trade Publication
This article announces a partnership reached among Hadasit, Harvard Medical School (HMS), and Brigham and Women's Hospital (BWH) to develop a new orally administered therapeutic option for autoimmune diseases. Comments from Professor Shlomo Mor-Yosef, director general of Hadassah Medical Organization, are included. Particular focus is given to the combination therapy. It also presents information on results of pre-clinical studies and the etiology of autoimmune diseases.


Related Articles

  • Out, but not down Sorting out the Hadassah resignation. BERKMAN, JACOB // New Jersey Jewish News;1/14/2010, Vol. 64 Issue 2, p24 

    The article focuses on the confusion on the resignation of director general of the Hadassah Medical Organization in Jerusalem Shlomo Mor-Yosef, which was reported that he is leaving because has been unhappy in his post for years.

  • The Other Crippling Joint Disease. Bjerklie, David // Time;12/9/2002, Vol. 160 Issue 24, p72 

    Discusses rheumatoid arthritis (RA) and how it differs from osteoarthritis. Idea that RA is a systemic disease, an autoimmune disorder in which one's defense system attacks the joints by way of the thin layer of cells called the synovium that line and lubricate the joints; Symptoms of swollen...

  • Pure red cell aplasia associated with type I autoimmune polyglandular syndrome--successful response to treatment with mycophenolate mofetil: case report and review of literature. Bakrac, Milena; Jurisic, Vladimir; Kostic, Tanja; Popovic, Vera; Pekic, Sandra; Kraguljac, Nada; Colovic, Milica // Journal of Clinical Pathology;Jun2007, Vol. 60 Issue 6, p717 

    The article describes the case of a 33-year old woman who had pure red cell aplasia (PRCA) that is associated with type 1 autoimmune polyglandular syndrome. PRCA is a hematological condition that is characterized by anemia, reticulocytopenia and erythroid hypoplasia. After the patient was...

  • Autoimmune pancytopenia following combination chemotherapy for chronic lymphocytic leukaemia. S MacCallum // Journal of Clinical Pathology;May2009, Vol. 62 Issue 5, p468 

    Autoimmune haemolysis or thrombocytopenia can complicate purine nucleoside monotherapy for chronic lymphocytic leukaemia (CLL), but Evans syndrome is rare. This is a report of the occurrence of pancytopenia secondary to a unique combination of red cell aplasia with autoimmune thrombocytopenia...

  • Nationwide survey on current treatments for IgA nephropathy in Japan. Matsuzaki, Keiichi; Suzuki, Yusuke; Nakata, Junichiro; Sakamoto, Naoko; Horikoshi, Satoshi; Kawamura, Tetsuya; Matsuo, Seiichi; Tomino, Yasuhiko // Clinical & Experimental Nephrology;Dec2013, Vol. 17 Issue 6, p827 

    Background: A wide variety of treatments, including tonsillectomy and steroid pulse therapy (TSP), are performed for the various stages of IgA nephropathy (IgAN) in Japan. However, the current status of treatments for IgAN patients in Japan is still unclear. The objective of the present study...

  • 17β-Estradiol Enhances the Efficacy of Adipose-Derived Mesenchymal Stem Cells on Remyelination in Mouse Model of Multiple Sclerosis. Kashani, Iraj Ragerdi; Hedayatpour, Azim; Pasbakhsh, Parichehr; Kafami, Leya; Atlasi, Nader; Mahabadi, Vahid Pirhajati; Mamoudi, Reza; Baazm, Maryam // Acta Medica Iranica;2012, Vol. 50 Issue 12, p789 

    Previous studies have demonstrated the potential of monotherapy with either mesenchymal stem cells (MSCs) or estrogen in autoimmune and cuprizone models of multiple sclerosis (MS). The aim of this study was to examine the effects of co-administration of 17β-estradiol (E2) and adipose-derived...

  • Partners HealthCare Center for Connected Health. Ternullo, Joseph; Jethwani, Kamal; Lane, Susan; Myint-U, Khinlei; Havasy, Robert; Carter, Michael; Kvedar, Joseph // Telemedicine & e-Health;May2013, Vol. 19 Issue 5, p363 

    This article reviews the history, current status, and future plans of the Partners HealthCare Center for Connected Health (the Center). Established in 1995 by Harvard Medical School teaching hospitals, the Center develops strategies to move healthcare from the hospital and doctor's office into...

  • An evaluation of knowledge, attitude and practices about prescribing fixed dose combinations among resident doctors. Goswami, Nimit; Gandhi, Anuradha; Patel, Prakruti; Dikshit, Ramkumar // Perspectives in Clinical Research;Apr-Jun2013, Vol. 4 Issue 2, p130 

    Background: Fixed Dose Combinations (FDCs) improve patient compliance and decrease pill burden. However, irrational prescribing of FDCs is a major health concern. As resident doctors are primarily involved in patient management at tertiary care hospitals, knowledge about prescribing FDCs is of...

  • Combined Treatment with Myo-Inositol and Selenium Ensures Euthyroidism in Subclinical Hypothyroidism Patients with Autoimmune Thyroiditis. Nordio, Maurizio; Pajalich, Raffaella // Journal of Thyroid Research;2013, p1 

    Hashimoto’s thyroiditis (HT), also known as chronic lymphocytic thyroiditis or chronic autoimmune thyroiditis, is the most common form of thyroiditis affecting more than 10% of females and 2% of males. The present study aims to evaluate the beneficial effect of a combined treatment,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics